Review
Published on 10 Apr 2025
Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1578940
- 189 views
Type at least 3 characters
7,540 articles
Original Research
Published on 10 Apr 2025
Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560717
- 268 views
Study Protocol
Published on 10 Apr 2025
Perioperative the BTLA inhibitor (tifcemalimab) combined with toripalimab and chemotherapy for resectable locally advanced thoracic esophageal squamous cell carcinoma trial (BT-NICE trial): a prospective, single-arm, exploratory study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1542877
- 222 views
Original Research
Accepted on 09 Apr 2025
Pan-Cancer Analysis of Phagocytosis Regulators in Female-Specific Cancers: A Focus on HMGB2
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565924
Case Report
Accepted on 09 Apr 2025
A novel chemotherapy-free regimen combined with photodynamic therapy, target therapy, and immunotherapy in a geriatric male with huge recurrent scalp and facial angiosarcoma: a report of an extremely rare case and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1556493
Systematic Review
Accepted on 09 Apr 2025
Global research status and frontiers on ferroptosis in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1549600
Review
Accepted on 09 Apr 2025
Histone modifications and metabolic reprogramming in Tumor-associated macrophages: a potential target of tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1521550
Original Research
Published on 09 Apr 2025
Exploring the role of LOX family in glioma progression and immune modulation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1512186
- 282 views
Original Research
Published on 09 Apr 2025
Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1537785
- 252 views
Review
Published on 09 Apr 2025
Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1536428
- 333 views
Original Research
Published on 09 Apr 2025
Investigation of the role of GEM in systemic lupus erythematosus through multi-omics joint analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1569605
- 236 views
Case Report
Published on 09 Apr 2025
Case Report: Rapid response to gemtuzumab-ozogamicin in a pediatric patient with refractory systemic mastocytosis with AML1::ETO+ acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1566805
- 195 views
Original Research
Published on 09 Apr 2025
Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557154
- 257 views
Original Research
Accepted on 08 Apr 2025
IFN-Îł-mediated suppression of ANGPT2-Tie2 in endothelial cells facilitates tumor vascular normalization during immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1551322
- 110 views
Original Research
Accepted on 08 Apr 2025
The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1579420
Mini Review
Accepted on 08 Apr 2025
Metabolic Reprogramming and Immune Microenvironment Characteristics in Laryngeal Carcinoma: Advances in Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1589243